340 related articles for article (PubMed ID: 25761664)
61. Capture and release of cancer cells based on sacrificeable transparent MnO2 nanospheres thin film.
Huang Q; Chen B; He R; He Z; Cai B; Xu J; Qian W; Chan HL; Liu W; Guo S; Zhao XZ; Yuan J
Adv Healthc Mater; 2014 Sep; 3(9):1420-5. PubMed ID: 24652776
[TBL] [Abstract][Full Text] [Related]
62. Multi-targeting magnetic hyaluronan capsules efficiently capturing circulating tumor cells.
Ma S; Zhou X; Chen Q; Jiang P; Lan F; Yi Q; Wu Y
J Colloid Interface Sci; 2019 Jun; 545():94-103. PubMed ID: 30875509
[TBL] [Abstract][Full Text] [Related]
63. Highly efficient assay of circulating tumor cells by selective sedimentation with a density gradient medium and microfiltration from whole blood.
Park JM; Lee JY; Lee JG; Jeong H; Oh JM; Kim YJ; Park D; Kim MS; Lee HJ; Oh JH; Lee SS; Lee WY; Huh N
Anal Chem; 2012 Sep; 84(17):7400-7. PubMed ID: 22881997
[TBL] [Abstract][Full Text] [Related]
64. High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (CTCs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles.
Wang Z; Sun N; Liu H; Chen C; Ding P; Yue X; Zou H; Xing C; Pei R
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39586-39593. PubMed ID: 31577122
[TBL] [Abstract][Full Text] [Related]
65. Role of the EpCAM (CD326) in prostate cancer metastasis and progression.
Ni J; Cozzi PJ; Duan W; Shigdar S; Graham PH; John KH; Li Y
Cancer Metastasis Rev; 2012 Dec; 31(3-4):779-91. PubMed ID: 22718399
[TBL] [Abstract][Full Text] [Related]
66. Nanoparticle-mediated binning and profiling of heterogeneous circulating tumor cell subpopulations.
Mohamadi RM; Besant JD; Mepham A; Green B; Mahmoudian L; Gibbs T; Ivanov I; Malvea A; Stojcic J; Allan AL; Lowes LE; Sargent EH; Nam RK; Kelley SO
Angew Chem Int Ed Engl; 2015 Jan; 54(1):139-43. PubMed ID: 25377874
[TBL] [Abstract][Full Text] [Related]
67. Cysteine-poor region-specific EpCAM monoclonal antibody recognizing native tumor cells with high sensitivity.
Takao M; Nagai Y; Torii T
Monoclon Antib Immunodiagn Immunother; 2013 Apr; 32(2):73-80. PubMed ID: 23607341
[TBL] [Abstract][Full Text] [Related]
68. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
[TBL] [Abstract][Full Text] [Related]
69. Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.
Wang G; Benasutti H; Jones JF; Shi G; Benchimol M; Pingle S; Kesari S; Yeh Y; Hsieh LE; Liu YT; Elias A; Simberg D
Colloids Surf B Biointerfaces; 2018 Jan; 161():200-209. PubMed ID: 29080504
[TBL] [Abstract][Full Text] [Related]
70. Expression profiling of circulating tumor cells in metastatic breast cancer.
Lang JE; Scott JH; Wolf DM; Novak P; Punj V; Magbanua MJ; Zhu W; Mineyev N; Haqq CM; Crothers JR; Esserman LJ; Tripathy D; van 't Veer L; Park JW
Breast Cancer Res Treat; 2015 Jan; 149(1):121-31. PubMed ID: 25432738
[TBL] [Abstract][Full Text] [Related]
71. EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation.
Vila A; Abal M; Muinelo-Romay L; Rodriguez-Abreu C; Rivas J; López-López R; Costa C
PLoS One; 2016; 11(10):e0163705. PubMed ID: 27711186
[TBL] [Abstract][Full Text] [Related]
72. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
[TBL] [Abstract][Full Text] [Related]
73. Greatly Enhanced CTC Culture Enabled by Capturing CTC Heterogeneity Using a PEGylated PDMS-Titanium-Gold Electromicrofluidic Device with Glutathione-Controlled Gentle Cell Release.
Kwizera EA; Ou W; Lee S; Stewart S; Shamul JG; Xu J; Tait N; Tkaczuk KHR; He X
ACS Nano; 2022 Jul; 16(7):11374-11391. PubMed ID: 35797466
[TBL] [Abstract][Full Text] [Related]
74. Micropallet arrays for the capture, isolation and culture of circulating tumor cells from whole blood of mice engrafted with primary human pancreatic adenocarcinoma.
Gach PC; Attayek PJ; Whittlesey RL; Yeh JJ; Allbritton NL
Biosens Bioelectron; 2014 Apr; 54():476-83. PubMed ID: 24316450
[TBL] [Abstract][Full Text] [Related]
75. Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE/FACS) for molecular profiling.
Magbanua MJ; Park JW
Methods; 2013 Dec; 64(2):114-8. PubMed ID: 23896286
[TBL] [Abstract][Full Text] [Related]
76. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM
Lampignano R; Yang L; Neumann MHD; Franken A; Fehm T; Niederacher D; Neubauer H
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858218
[TBL] [Abstract][Full Text] [Related]
77. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
[TBL] [Abstract][Full Text] [Related]
78. Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis.
Thege FI; Lannin TB; Saha TN; Tsai S; Kochman ML; Hollingsworth MA; Rhim AD; Kirby BJ
Lab Chip; 2014 May; 14(10):1775-84. PubMed ID: 24681997
[TBL] [Abstract][Full Text] [Related]
79. Efficient Purification and Release of Circulating Tumor Cells by Synergistic Effect of Biomarker and SiO2 @Gel-Microbead-Based Size Difference Amplification.
Huang Q; Cai B; Chen B; Rao L; He Z; He R; Guo F; Zhao L; Kondamareddy KK; Liu W; Guo S; Zhao XZ
Adv Healthc Mater; 2016 Jul; 5(13):1554-9. PubMed ID: 27028055
[TBL] [Abstract][Full Text] [Related]
80. Capture of Tumor Cells on Anti-EpCAM-Functionalized Poly(acrylic acid)-Coated Surfaces.
Andree KC; Barradas AM; Nguyen AT; Mentink A; Stojanovic I; Baggerman J; van Dalum J; van Rijn CJ; Terstappen LW
ACS Appl Mater Interfaces; 2016 Jun; 8(23):14349-56. PubMed ID: 27187784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
